• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A case of primary (AL) amyloidosis with predominantly vascular amyloid deposition in the kidney.一例原发性(AL)淀粉样变性,主要表现为肾脏血管淀粉样沉积。
CEN Case Rep. 2015 Nov;4(2):151-156. doi: 10.1007/s13730-014-0157-7. Epub 2014 Dec 2.
2
The clinicopathological spectrum of renal amyloidosis.肾淀粉样变性的临床病理谱。
Zhonghua Yi Xue Za Zhi (Taipei). 1994 Oct;54(4):230-9.
3
[Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].[与单克隆丙种球蛋白病相关的肾脏疾病:诊断与治疗进展]
Presse Med. 2012 Mar;41(3 Pt 1):276-89. doi: 10.1016/j.lpm.2011.11.008. Epub 2012 Jan 13.
4
Resolution of primary amyloidosis by melphalan and prednisolone: a case report.美法仑和泼尼松龙治疗原发性淀粉样变性的病例报告
Clin Nephrol. 2005 Mar;63(3):215-20. doi: 10.5414/cnp63215.
5
A rare lung nodule consisting of adenocarcinoma and amyloid deposition in a patient with primary systemic AL amyloidosis.一名原发性系统性AL淀粉样变性患者出现的罕见肺结节,由腺癌和淀粉样沉积组成。
Intern Med. 2011;50(3):243-6. doi: 10.2169/internalmedicine.50.4094. Epub 2011 Feb 1.
6
[More than 10 years of complete remission of monoclonal gammopathy of undetermined significance and cessation of light chain deposition disease-associated nephrotic syndrome following treatment with vincristine, adriamycin and high-dose dexamethasone (VAD)].长春新碱、阿霉素和大剂量地塞米松(VAD)治疗后意义未明的单克隆丙种球蛋白病完全缓解超过10年且轻链沉积病相关肾病综合征停止进展
Vnitr Lek. 2010 Mar;56(3):240-6.
7
[IgM-lambda multiple myeloma presenting with systemic amyloidosis].[以系统性淀粉样变性为表现的IgM-λ型多发性骨髓瘤]
Rinsho Ketsueki. 2009 Dec;50(12):1711-4.
8
Urinary findings in renal light chain-derived amyloidosis and light chain deposition disease.肾轻链型淀粉样变性和轻链沉积病的尿液检查结果
Clin Lymphoma Myeloma. 2009 Jun;9(3):234-8. doi: 10.3816/CLM.2009.n.046.
9
A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine.一例原发性免疫球蛋白轻链淀粉样变性伴尿本周蛋白延迟出现的病例。
Nephrology (Carlton). 2004 Jun;9(3):122-5. doi: 10.1111/j.1440-1797.2004.00246.x.
10
[kappa-light chain amyloidosis of the liver, a rare cause of liver enzyme elevation].
Dtsch Med Wochenschr. 2008 May;133(21):1116-20. doi: 10.1055/s-2008-1077225.

引用本文的文献

1
Late evolution of an arteriovenous fistula in renal transplant: a case report.肾移植中动静脉瘘的晚期演变:一例报告
BMC Nephrol. 2025 Jul 16;26(1):391. doi: 10.1186/s12882-025-04327-5.
2
On the Role of Platelet-Generated Amyloid Beta Peptides in Certain Amyloidosis Health Complications.血小板生成的β淀粉样肽在某些淀粉样变性并发症中的作用。
Front Immunol. 2020 Oct 2;11:571083. doi: 10.3389/fimmu.2020.571083. eCollection 2020.
3
Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience.达雷妥尤单抗单药治疗重度 AL 淀粉样变性且经活检证实有肾脏受累患者:一项真实病例经验
J Clin Med. 2020 Oct 9;9(10):3232. doi: 10.3390/jcm9103232.
4
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation.重度AL淀粉样变性且经活检证实有肾脏受累而不符合骨髓移植条件的患者的预后。
J Nephrol. 2021 Feb;34(1):231-240. doi: 10.1007/s40620-020-00748-7. Epub 2020 May 29.

本文引用的文献

1
A clinicopathological analysis in a large cohort of Chinese patients with renal amyloid light-chain amyloidosis.在中国一大群肾轻链淀粉样变性症患者中的临床病理分析。
Nephrol Dial Transplant. 2013 Mar;28(3):689-97. doi: 10.1093/ndt/gfs501. Epub 2012 Nov 25.
2
Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis.淀粉样纤维蛋白命名:国际淀粉样变性学会命名委员会 2012 年推荐意见。
Amyloid. 2012 Dec;19(4):167-70. doi: 10.3109/13506129.2012.734345. Epub 2012 Nov 1.
3
Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney.肾脏血管受限沉积的免疫球蛋白轻链淀粉样变(AL)患者的临床特征。
Nephrol Dial Transplant. 2012 Mar;27(3):1097-101. doi: 10.1093/ndt/gfr381. Epub 2011 Nov 7.
4
Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study.每周一次和每周两次硼替佐米治疗复发系统性 AL 淀粉样变性患者的疗效和安全性:一项 1/2 期研究的结果。
Blood. 2011 Jul 28;118(4):865-73. doi: 10.1182/blood-2011-02-334227. Epub 2011 May 11.
5
Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis.硼替佐米联合或不联合地塞米松治疗原发性系统性淀粉样变(轻链型)。
J Clin Oncol. 2010 Feb 20;28(6):1031-7. doi: 10.1200/JCO.2009.23.8220. Epub 2010 Jan 19.
6
Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study.系统性 AL 淀粉样变性患者使用每周及每两周一次硼替佐米的研究:一项 1 期剂量递增研究结果
Blood. 2009 Aug 20;114(8):1489-97. doi: 10.1182/blood-2009-02-203398. Epub 2009 Jun 4.
7
Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.慢性肾病患者血清和尿液多克隆游离轻链的定量评估
Clin J Am Soc Nephrol. 2008 Nov;3(6):1684-90. doi: 10.2215/CJN.02290508.
8
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis.未经治疗的AL淀粉样变性患者血清游离轻链检测的评估
Haematologica. 2008 Mar;93(3):459-62. doi: 10.3324/haematol.11687. Epub 2008 Feb 20.
9
Evaluation of abdominal fat pad aspiration cytology and grading for detection in systemic amyloidosis.腹部脂肪垫穿刺细胞学检查及分级在系统性淀粉样变检测中的评估
Acta Cytol. 2007 Nov-Dec;51(6):860-4. doi: 10.1159/000325861.
10
Amyloidosis-associated kidney disease.淀粉样变性相关性肾病
J Am Soc Nephrol. 2006 Dec;17(12):3458-71. doi: 10.1681/ASN.2006050460. Epub 2006 Nov 8.

一例原发性(AL)淀粉样变性,主要表现为肾脏血管淀粉样沉积。

A case of primary (AL) amyloidosis with predominantly vascular amyloid deposition in the kidney.

作者信息

Murakami Yoichi, Hattori Soken, Sugiyama Fumiko, Yoshikawa Kazuyuki, Sugiura Takeshi, Matsushima Hideki

机构信息

Department of Nephrology, Seirei Mikatahara General Hospital, 3453 Mitakahara-cho, Kita-ku, Hamamatsu, Shizuoka, 433-8558, Japan.

出版信息

CEN Case Rep. 2015 Nov;4(2):151-156. doi: 10.1007/s13730-014-0157-7. Epub 2014 Dec 2.

DOI:10.1007/s13730-014-0157-7
PMID:28509092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5411632/
Abstract

We report a 70-year-old man with primary (AL) amyloidosis with predominantly vascular deposition of amyloid diagnosed by renal biopsy, who was successfully treated using two chemotherapy regimens. There was rapid elevation of the serum creatinine level without remarkable proteinuria or hematuria. Renal histological examination showed some thickened arterial walls with amyloid fibril accumulation, and only a small amount of amyloid deposition in the glomeruli. Immunohistochemical examination was positive for anti-kappa staining. Serum immunoelectrophoresis and immunofixation testing did not show monoclonal proteins, and urine immunoelectrophoresis did not show Bence-Jones proteins. Serum free light chain (FLC) analysis showed that the serum FLC level and FLC kappa/lambda ratio were abnormally high for his renal function. He received two courses of VAD (vincristine, doxorubicin, and dexamethasone), followed by BD (bortezomib and dexamethasone), resulting in a hematologic partial response. Renal amyloidosis with vascular-limited amyloid deposition has few urinary findings. Early diagnosis of this condition is challenging, because kidney biopsies are not usually performed in patients without significant urinary findings. We suggest several currently available methods of achieving earlier detection of this condition.

摘要

我们报告了一名70岁男性,经肾活检诊断为原发性(AL)淀粉样变性,主要为淀粉样蛋白血管沉积,该患者使用两种化疗方案成功治愈。血清肌酐水平迅速升高,无明显蛋白尿或血尿。肾脏组织学检查显示一些动脉壁增厚,有淀粉样纤维积聚,肾小球内仅有少量淀粉样蛋白沉积。免疫组织化学检查抗κ染色呈阳性。血清免疫电泳和免疫固定试验未显示单克隆蛋白,尿免疫电泳未显示本周氏蛋白。血清游离轻链(FLC)分析显示,其血清FLC水平和FLC κ/λ比值相对于其肾功能异常升高。他接受了两个疗程的VAD(长春新碱、阿霉素和地塞米松)治疗,随后接受BD(硼替佐米和地塞米松)治疗,产生了血液学部分缓解。血管局限性淀粉样沉积的肾淀粉样变性几乎没有尿液检查结果。这种情况的早期诊断具有挑战性,因为通常不会对没有明显尿液检查结果的患者进行肾活检。我们提出了几种目前可用于更早检测这种情况的方法。